Novel 3-Azaindolyl-4-arylmaleimides Exhibiting Potent Antiangiogenic Efficacy, Protein Kinase Inhibition, and Antiproliferative Activity

被引:36
作者
Ganser, Christopher [1 ]
Lauermann, Eva [1 ]
Maderer, Annett [2 ]
Stauder, Torsten [3 ]
Kramb, Jan-Peter [1 ]
Plutizki, Stanislav [1 ]
Kindler, Thomas [3 ]
Moehler, Markus [2 ]
Dannhardt, Gerd [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Dept Pharm, Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Dept Internal Med 1, D-6500 Mainz, Germany
[3] Johannes Gutenberg Univ Mainz, Dept Internal Med 3, Mainz, Germany
关键词
PLUS IRINOTECAN; ANGIOGENESIS; CANCER; DIFFERENTIATION; MECHANISMS; APOPTOSIS; ACYLATION; ERLOTINIB; GROWTH; ASSAY;
D O I
10.1021/jm301217c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Tumor growth and metastasis are highly associated with the overexpression of protein kinases (PKs) regulating cell growth, apoptosis resistance, and prolonged cell survival. This study describes novel azaindolyl-maleimides with significant inhibition of PKs, such as VEGFR, FLT-3, and GSK-3 beta which are related to carcinogenesis. Furthermore, these compounds exhibit high kinase selectivity and potent inhibition of angiogenesis and cell proliferation, offering versatile options in cancer treatment strategies.
引用
收藏
页码:9531 / 9540
页数:10
相关论文
共 40 条
[1]  
Aitkenhead M, 1998, DEV DYNAM, V212, P1
[2]   Di-tert-butyl dicarbonate and 4-(dimethylamino)pyridine revisited.: Their reactions with amines and alcohols [J].
Basel, Y ;
Hassner, A .
JOURNAL OF ORGANIC CHEMISTRY, 2000, 65 (20) :6368-6380
[3]   Tyrosine kinase receptors as attractive targets of cancer therapy [J].
Bennasroune, A ;
Gardin, A ;
Aunis, D ;
Crémel, G ;
Hubert, P .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 50 (01) :23-38
[4]   Mechanisms of angiogenesis and arteriogenesis [J].
Carmeliet, P .
NATURE MEDICINE, 2000, 6 (04) :389-395
[5]   Angiogenesis in cancer and other diseases [J].
Carmeliet, P ;
Jain, RK .
NATURE, 2000, 407 (6801) :249-257
[6]   Excited state tautomerization of azaindole [J].
Cash, MT ;
Schreiner, PR ;
Phillips, RS .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2005, 3 (20) :3701-3706
[7]   Molecular mechanisms of blood vessel growth [J].
Conway, EM ;
Collen, D ;
Carmeliet, P .
CARDIOVASCULAR RESEARCH, 2001, 49 (03) :507-521
[8]   Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J].
Cunningham, D ;
Humblet, Y ;
Siena, S ;
Khayat, D ;
Bleiberg, H ;
Santoro, A ;
Bets, D ;
Mueser, M ;
Harstrick, A ;
Verslype, C ;
Chau, I ;
Van Cutsem, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) :337-345
[9]  
Dannhardt G., 2011, EP Patent, Patent No. [08858282.1, 088582821]
[10]  
Dannhardt G., 2011, Patent No. [WO 2011/73092 A1, 201173092]